FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Aug 26, 2013
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on August 26, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- August 26, 2013
- Product Type
- Biologics
View Company Profile
ID · e81ba3f8-c357-4ac9-b7b3-50d0191e893f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 847982
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 12, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 2, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 4, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1151448 - 2021-08-12
- FDA Inspection 1063785 - 2018-08-02
- FDA Inspection 940667 - 2015-09-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.